Stock Taper
EARNINGS CALL ARCHIVE 2 CALLS ON FILE
EW — Edwards Lifesciences Corporation
NYSE
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

FEB 10, 2026
REVENUE
$1.57B +1.1%
NET MARGIN
5.8% -12.9 PTS
EPS
$0.16 -68.0%
FREE CASH FLOW
$353.5M -31.5%

No summary has been written for this call yet.